• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION(RIDGEFIELD) SYNVISC ONE; MOZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION(RIDGEFIELD) SYNVISC ONE; MOZ Back to Search Results
Lot Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Pain (1994); Synovitis (2094); Arthralgia (2355); Vascular Dissection (3160)
Event Date 01/01/2021
Event Type  Injury  
Manufacturer Narrative
Sanofi company comment dated 01-nov-2022: this case involves an unknown age male patient whose doctor tried to inject right knee in the time, he hit patient's vein while being treated with hylan g-f 20, sodium hyaluronate [synvisc one].Based on the available information, causal relationship between the events and suspect product could not be denied.However, further information regarding patient¿s medical history, past medications, concomitant medications, post injection routine, injection technique and other risk factors would aid in better case assessment.
 
Event Description
Doctor tried to inject right knee in the time, he hit patients vein [venous injury] inflamed synovitis in right knee [synovitis of knee] ([aching (r) knee]) case narrative: initial information received on (b)(6) 2022 from canada regarding an unsolicited valid serious case received from a consumer/non-hcp.This case involves an unknown age male patient who reported that doctor tried to inject right knee in the time, he hit patient's vein and inflamed synovitis in right knee with the use of medical device hylan g-f 20, sodium hyaluronate [synvisc one].The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.In 2021, the patient received synvisc one injection in his right knee via intra-articular route (with an unknown batch number, expiry date, strength, dose, frequency) for product used for unknown indication.Information regarding batch number cannot be requested.Reportedly, the patient had received 3 shots so far, the first 2 injections were good and nothing went wrong.On an unknown date in 2021, on same day (latency) while receiving injection, when the doctor tried to inject his right knee in the time, he hit his vein (venous injury) (medically significant).The patient had severe pain after his last injection (arthralgia, onset and latency: unknown) and the doctor diagnosed it as an inflamed synovitis in his right knee (synovitis; onset and latency: unknown).Now it had been almost a year and it seemed the effect was wearing off.That can exclude him from another shot in future.Action taken: not applicable for all the events.Corrective treatment: not reported for the events.Outcome was unknown for all the events.A product technical complaint (ptc) was initiated, and the results were pending for the same.
 
Manufacturer Narrative
(b)(4) company comment dated 01-nov-2022: this case involves an unknown age male patient whose doctor tried to inject right knee in the time, he hit patient's vein while being treated with hylan g-f 20, sodium hyaluronate [synvisc one].Based on the available information, causal relationship between the events and suspect product could not be denied.However, further information regarding patient¿s medical history, past medications, concomitant medications, post injection routine, injection technique and other risk factors would aid in better case assessment.
 
Event Description
Doctor tried to inject right knee in the time, he hit patients vein [venous injury] inflamed synovitis in right knee [synovitis of knee] ([aching (r) knee]).Case narrative: initial information received on 26-oct-2022 from canada regarding an unsolicited valid serious case received from a consumer/non-hcp.This case involves an unknown age male patient who reported that doctor tried to inject right knee in the time, he hit patient's vein and inflamed synovitis in right knee with the use of medical device hylan g-f 20, sodium hyaluronate [synvisc one].The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.In 2021, the patient received synvisc one injection in his right knee via intra-articular route (with an unknown batch number, expiry date, strength, dose, frequency) for product used for unknown indication.Information regarding batch number cannot be requested.Reportedly, the patient had received 3 shots so far, the first 2 injections were good and nothing went wrong.On an unknown date in 2021, on same day (latency) while receiving injection, when the doctor tried to inject his right knee in the time, he hit his vein (venous injury) (medically significant).The patient had severe pain after his last injection (arthralgia, onset and latency: unknown) and the doctor diagnosed it as an inflamed synovitis in his right knee (synovitis; onset and latency: unknown).Now it had been almost a year and it seemed the effect was wearing off.That can exclude him from another shot in future.Action taken: not applicable for all the events.Corrective treatment: not reported for the events.Outcome was unknown for all the events.A product technical complaint (ptc) was initiated, and the results were pending for the same.Upon internal review on 07-nov-2022 case (b)(4) be deleted) was identified to be duplicate of (b)(4) (to be retained).Hence, all the information from the case (b)(4) (to be deleted) has been merged in case id (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC ONE
Type of Device
MOZ
Manufacturer (Section D)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer (Section G)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer Contact
heather schiappacasse
55 corporate drive, ms 55b-220
a
bridgewater 08807
MDR Report Key15725180
MDR Text Key303045460
Report Number2246315-2022-00134
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/04/2022
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received11/11/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient SexMale
-
-